drugset / Trial / NCT00312156

Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes

NCT00312156

Phase 3 Completed 347 enrolled Novo Nordisk A/S
RandomizedParallel-groupOpen-labelTreatment

Summary

The trial is conducted in Europe and Middle East. The aim of the trial is to compare the use of Insulin Detemir once or twice daily combined with mealtime Insulin Aspart against that of NPH Insulin once or twice daily combined with mealtime Insulin Aspart. The trial involves children and adolescents with Type 1 Diabetes.

Timeline

Start
2002-08
Primary completion
2003-08
Completion
2003-08

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin NPH Protein / enzyme biologic
Subject insulin detemir Protein / enzyme biologic
Background insulin aspart Protein / enzyme biologic